GW-842,166X

From WikiMD's WELLNESSPEDIA

File:GW-842,166X Structure.svg
Chemical structure of GW-842,166X

GW-842,166X is a chemical compound that has been studied for its potential effects on various biological systems. It is of interest in the field of pharmacology and biochemistry due to its unique structure and potential therapeutic applications.

Chemical Properties[edit]

GW-842,166X is characterized by its distinct chemical structure, which includes several functional groups that contribute to its biological activity. The compound's molecular formula is C20H25NO3, and it has a molecular weight of 327.42 g/mol.

Mechanism of Action[edit]

The mechanism of action of GW-842,166X involves interaction with specific receptors in the body. It is known to modulate the activity of certain enzymes and ion channels, which can lead to changes in cellular signaling pathways. This modulation can result in various physiological effects, depending on the target tissue and the concentration of the compound.

Potential Applications[edit]

GW-842,166X has been investigated for its potential use in treating a range of conditions. Its ability to influence cell signaling pathways makes it a candidate for research in areas such as neurology, cardiology, and oncology.

Research and Development[edit]

Research on GW-842,166X is ongoing, with studies focusing on its pharmacokinetics, pharmacodynamics, and potential therapeutic benefits. Preclinical studies have shown promising results, but further research is needed to fully understand its efficacy and safety profile.

Safety and Toxicology[edit]

The safety profile of GW-842,166X is still under investigation. Initial studies suggest that it has a moderate safety margin, but long-term studies are required to assess its potential toxicological effects.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.